| Dr Thomas Whiteside, MD | |
|
390 E Longview St, Fayetteville, AR 72703-4618 | |
| (479) 442-0144 | |
| (479) 442-4557 |
| Full Name | Dr Thomas Whiteside |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 28 Years |
| Location | 390 E Longview St, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457324055 | NPI | - | NPPES |
| E2371 | Other | AR | AR LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | E2371 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Regional Medical Center | Fayetteville, AR | Hospital |
| Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
| Northwest Medical Center-springdale | Springdale, AR | Hospital |
| Siloam Springs Regional Hospital | Siloam springs, AR | Hospital |
| Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Arkansas Pathology Associates Pa | 8729013495 | 11 |
| Cherokee Nation | 5799698742 | 329 |
News Archive
Among women diagnosed with early-stage breast cancer in California, the percentage undergoing a double mastectomy increased substantially between 1998 and 2011, although this procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation, according to a study in the September 3 issue of JAMA.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated and dosing has begun.
Both studies appear in the September issue of Neuropsychology, which is published by the American Psychological Association (APA). Psychologists focus on early detection in part because current medications are useful only when given very early in the course of the disease.
ARTES Biotechnology, specialized in recombinant protein production and process development in microbial expression systems, started a development collaboration for two vaccines together with global biopharmaceutical company Crucell. Crucell is focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide.
› Verified 4 days ago
| Entity Name | Northwest Arkansas Pathology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306819263 PECOS PAC ID: 8729013495 Enrollment ID: O20051011000115 |
News Archive
Among women diagnosed with early-stage breast cancer in California, the percentage undergoing a double mastectomy increased substantially between 1998 and 2011, although this procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation, according to a study in the September 3 issue of JAMA.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated and dosing has begun.
Both studies appear in the September issue of Neuropsychology, which is published by the American Psychological Association (APA). Psychologists focus on early detection in part because current medications are useful only when given very early in the course of the disease.
ARTES Biotechnology, specialized in recombinant protein production and process development in microbial expression systems, started a development collaboration for two vaccines together with global biopharmaceutical company Crucell. Crucell is focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Whiteside, MD 390 E Longview St, Fayetteville, AR 72703-4618 Ph: (479) 442-0144 | Dr Thomas Whiteside, MD 390 E Longview St, Fayetteville, AR 72703-4618 Ph: (479) 442-0144 |
News Archive
Among women diagnosed with early-stage breast cancer in California, the percentage undergoing a double mastectomy increased substantially between 1998 and 2011, although this procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation, according to a study in the September 3 issue of JAMA.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated and dosing has begun.
Both studies appear in the September issue of Neuropsychology, which is published by the American Psychological Association (APA). Psychologists focus on early detection in part because current medications are useful only when given very early in the course of the disease.
ARTES Biotechnology, specialized in recombinant protein production and process development in microbial expression systems, started a development collaboration for two vaccines together with global biopharmaceutical company Crucell. Crucell is focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide.
› Verified 4 days ago
Dr. Paul R Hendrycy, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Bradley Dilday, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Jamie M Boone, D.O. Pathology Medicare: Medicare Enrolled Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Gregory Mckenzie, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 | |
Dr. Thomas J Simmons, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Saran Kraichoke, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 390 E Longview St, Fayetteville, AR 72703 Phone: 479-442-0144 Fax: 479-442-4557 | |
Dr. Robert Morris Levy, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, P&lms (113), Fayetteville, AR 72703 Phone: 479-443-4301 |